This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Emory University, Georgia Tech Research Corporation. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Atlanta, GA (US) (2022)
- Decatur, GA (US) (2023)
Company Filing History:
3 out of 1,024 
1 out of 2,193 
Years Active: 2022-2024
Title: Innovations by Inventor Sruthi Ravindranathan
Introduction
Sruthi Ravindranathan is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for cancer and viral infections. With a total of 3 patents, his work showcases innovative approaches to complex medical challenges.
Latest Patents
One of his latest patents is focused on "Compositions and uses of vasoactive intestinal peptide (VIP) antagonists." This disclosure relates to VIP antagonists for managing the treatment or prevention of cancer and viral infections. In certain embodiments, it discusses chimeric variants of VIP antagonists and pharmaceutical compositions comprising these peptides. Additionally, it contemplates methods of stimulating immune cells to target cancer by mixing immune cells in vitro with the disclosed peptides and administering an effective amount of stimulated immune cells to a subject in need of cancer treatment.
Another notable patent is titled "Nanoparticles conjugated with vasoactive intestinal peptide antagonists." This disclosure relates to compositions comprising an antagonist of vasoactive intestinal polypeptide signaling coupled to a nanoparticle, along with methods of use related to these compositions. In certain embodiments, the nanoparticle is a poloxamer-stabilized polypropylene sulfide nanoparticle.
Career Highlights
Sruthi has worked with prestigious institutions such as Emory University and Georgia Tech Research Corporation. His experience in these organizations has allowed him to collaborate on groundbreaking research and contribute to advancements in medical science.
Collaborations
Some of his notable coworkers include Edmund K Waller and Susan Thomas, who have also made significant contributions to their respective fields.
Conclusion
In summary, Sruthi Ravindranathan is a notable inventor whose work in the development of VIP antagonists and nanoparticle technologies has the potential to impact cancer treatment and viral infection management significantly. His innovative contributions continue to advance the field of biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile